ARTICLE | Clinical News
Mydicar: Phase II started
September 1, 2014 7:00 AM UTC
Celladon began a double-blind, placebo-controlled, U.K. Phase II trial to evaluate Mydicar in about 24 HF patients with an LVAD. The British Heart Foundation is partially funding the trial and Imperial College London is sponsoring it. ...